CIK: 1734424 - Address: C/O Annexon, Inc., 1400 Sierra Point Pkwy, Bldg C, Ste 200, Brisbane, CA 94005
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/4/26 16:30
3/2/26
ANNXAnnexon, Inc.DEHealthDrugPharmaceutical PreparationsDananberg JamieCAOChief MeS-325.430-6-4124D
2/20/26 16:30
2/18/26
ANNXAnnexon, Inc.DEHealthDrugPharmaceutical PreparationsDananberg JamieCAOChief MeS-275.100-5-773D
2/20/25 16:54
2/18/25
ANNXAnnexon, Inc.DEHealthDrugPharmaceutical PreparationsDananberg JamieCAOChief MeS-162.960-6-1433D
4/3/23 16:51
3/31/23
UBXUnity Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsDananberg JamieCAOChief MeS-11.7000-163D
3/15/23 17:02
3/14/23
UBXUnity Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsDananberg JamieCAOChief MeS-44.000-1-263D
2/3/23 16:33
2/2/23
UBXUnity Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsDananberg JamieCAOChief MeS-44.840-1-164D
12/15/22 16:44
12/14/22
UBXUnity Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsDananberg JamieCAOChief MeS-32.850-1-265D
9/15/22 16:10
9/14/22
UBXUnity Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsDananberg JamieCAOChief MeS-50.48000-11-2661D
6/28/22 18:11
6/27/22
UBXUnity Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsDananberg JamieCAOChief MeS-30.59000-4-1672D
6/22/22 16:49
6/21/22
UBXUnity Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsDananberg JamieCAOChief MeS-20.62000-4-1677D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact